Tarsadia Investments

Tarsadia Investments is a private investment firm and family office based in Newport Beach, California. Established in 1976, it focuses on providing capital and strategic support to growth-oriented companies. The firm pursues opportunities across a broad range of sectors, including healthtech and healthcare, fintech and financial services, real estate and proptech, technology, mobility, life sciences, and clean technology. By partnering with management teams, it aims to accelerate growth, drive value creation, and pursue attractive return potential.

David Browne

CFO

Mitch Caplan

President

Mitchell Caplan

President

Greg Casserly

CEO

Tushar Patel

Chairman and Founder

Gautam Patel

Managing Director

Darshan Patel

Associate

Rishi Reddy

Managing Director and Head of Venture and Growth

Rishi N. Reddy

Managing Director - Head of Venture and Growth

Jay Santoro

Vice President

38 past transactions

Pagos

Series A in 2023
Pagos is a company based in Wilmington, Delaware, founded in 2021. It specializes in developing a Software as a Service (SaaS) financial platform aimed at helping businesses enhance their payment processing efficiency. The platform offers tools to normalize, visualize, aggregate, and monitor payment data, which helps companies improve performance, increase sales, and reduce the overall cost of accepting payments. Additionally, Pagos provides an application programming interface (API) that enables merchant companies to optimize and manage their payments, fostering business growth and long-term customer relationships.

Envisics

Series C in 2023
Envisics Limited is an automotive technology company based in Milton Keynes, United Kingdom, specializing in the design and development of holographic projection systems and computation algorithms for head-up and head-mounted displays. Founded in 2009, the company focuses on light manipulation through phase-only holography, leveraging advanced holographic and laser-based technologies to deliver high-quality images. Envisics aims to transform automotive displays and enhance the in-car experience by partnering with leading automakers and tier-one suppliers. Its dynamic holography platform enables the creation of head-up display images that overlay information seamlessly onto the driver’s field of view, thereby improving safety and providing essential driving information without distraction.

Matterworks

Convertible Note in 2023
Matterworks is a developer of an artificial intelligence platform focused on advancing the field of metabolomics within the life sciences. The company's technology enhances analytical capabilities, allowing scientific researchers to conduct faster and more comprehensive metabolomic screenings. By facilitating the discovery and engineering processes, Matterworks aims to accelerate scientific progress and support innovation in various biological applications.

Fathom

Series B in 2022
Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.

Jüsto

Series B in 2022
Jüsto operates an online supermarket platform that enables doorstep delivery of groceries and related goods. The service offers a wide range of products, including fruits, vegetables, meat, dairy, beauty items, and household supplies, with a focus on convenient access to fresh, healthy options at affordable prices.

Kirilys Therapeutics

Seed Round in 2022
Kirilys is a biopharmaceutical company focused on developing precision oncology assets aimed at improving the quality of life for cancer patients. Currently in the preclinical stages, the firm is working on a drug that has shown promising potency, selectivity, and anti-tumor efficacy. This drug is designed to be administered orally, which may enhance its usability for clinicians. In addition to addressing various cancers, Kirilys is also dedicated to improving treatment options for patients with chronic kidney disease. Through its innovative approach, the company aims to contribute significantly to the field of oncology and patient care.

Chronus Health

Series A in 2022
Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

Petal

Series D in 2022
Petal Card, Inc. is a credit card company focused on providing financial access to individuals without traditional credit histories, such as students and immigrants. Founded in 2015 and based in New York, the company utilizes machine learning to analyze users' digital financial records, allowing for cash flow underwriting as an alternative to conventional credit scoring. This innovative approach enables Petal to offer higher credit limits and lower rates compared to competing credit cards. The company's flagship product, the Petal Visa, is designed to promote responsible spending and credit-building, accompanied by a user-friendly digital application for managing payments. Petal aims to make credit more honest, simple, and accessible, fostering a financial environment that encourages users to succeed.

AvantStay

Series B in 2021
Founded in 2016, AvantStay specializes in vacation home rentals. It operates across over 60 cities worldwide, offering a curated experience through its proprietary tech platform, which facilitates bookings and manages properties.

Konfio

Series E in 2021
Konfio is a financial services platform in Mexico that provides online lending and payment solutions for micro, small, and medium-sized businesses. It offers working capital and short-term loans, fixed-rate loans, corporate cards, and online payments. The platform uses a data-driven approach with proprietary analytics to measure creditworthiness and extend affordable credit to businesses underserved by traditional banks, supporting growth and productivity.

Bolttech

Series A in 2021
Bolttech is an international InsurTech company that develops an AI-based point-of-sale insurance platform. This platform offers a range of insurance products, including device protection, travel, motor, property, life, and digital insurance to consumers. Bolttech aims to create a technology-enabled ecosystem for protection and insurance, with a notable presence in Asia.

Konfio

Series E in 2021
Konfio is a financial services platform in Mexico that provides online lending and payment solutions for micro, small, and medium-sized businesses. It offers working capital and short-term loans, fixed-rate loans, corporate cards, and online payments. The platform uses a data-driven approach with proprietary analytics to measure creditworthiness and extend affordable credit to businesses underserved by traditional banks, supporting growth and productivity.

Nubank

Series G in 2021
Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.

Phil

Series D in 2021
Phil, Inc., founded in 2015 and based in San Francisco, California, specializes in improving patient access to essential medications through its innovative prescription management software. The company operates a specialty Rx distribution platform that automates medication refills according to prescription schedules, acting as an intermediary between patients, prescribers, manufacturers, and pharmacists. Phil also offers complimentary home delivery services for medications. Its technology-driven approach aims to remove barriers to medication access, ensuring seamless therapy initiation and adherence. By providing end-to-end visibility into the prescription life cycle, Phil helps maximize reimbursement for brands while enhancing patient outcomes and provider experiences.

Yieldstreet

Series C in 2021
Yieldstreet is a management platform that provides retail investors access to income-generating investment products. Founded in 2015, It gives individuals access to alternative investments that have traditionally been off-limits to the average investor. With over $2.5 billion invested across multiple asset classes, Yieldstreet is changing the way people generate passive income by lowering and removing the barriers that historically kept these lucrative opportunities far out of reach. In 2013, founders Milind Mehere and Michael Weisz were frustrated that many investment strategies were typically reserved only for institutions and the ultra-wealthy. Typically, the average investor was left to choose between the stock market and bonds with falling yields - with few options in between. Asset-based investments had longer hold periods and a higher barrier of entry, keeping them well out of reach of accredited investors — even more so for unaccredited investors. As a result, they decided to leverage the growing fintech disruption to give more people access to these previously restricted alternative investments. Milind’s background in building companies combined with Michael’s decade-plus experience in investing and fund management formed the core of Yieldstreet. Passion for their investors and employees as well as a willing embrace of innovation, has been part of Yieldstreet’s identity from the beginning. Each decision to leverage a new technology, or investment strategy, or originate a new deal is made to put investors first. That drive has propelled Yieldstreet across all 50 states, crossing $100M invested in less than eight quarters, with the $1B milestone coming only three years later. In 2019, Yieldstreet’s membership had grown to 100,000, and a savings account for members was launched. Yieldstreet, since its launch in 2015, has not deviated from its goal to change investing for the better, nor has it slowed down. Yieldstreet was ranked number 46 on the Inc. 5000 list of the fastest-growing companies and has been recognized by Built In as one of the Best Places to Work. Yieldstreet today delivers wealth generation options and alternative investments for more than 330,000 investors and has returned more than $1.3 billion in principal/interest. Many alternative investment platforms only focus on one asset class, such as real estate or art. Yieldstreet’s offerings, accessed through cash or a low-fee IRA, cover a wide range of asset classes — art, real estate, legal, corporates, consumer, and commercial, via single investments or funds. Yieldstreet also offers its members short-term notes on offerings with a hold period between 3 and 6 months, which generally boast higher interest rates than money markets and CDs. Yieldstreet is headquartered in New York and has offices in Brazil, Greece, and Malta. Michael Weisz serves as President and Milind Mehere serves as CEO. Together, they manage a team of more than 140 employees, all working toward Yieldstreet’s one goal: to change the way people invest for the better.

Phil

Series C in 2021
Phil, Inc., founded in 2015 and based in San Francisco, California, specializes in improving patient access to essential medications through its innovative prescription management software. The company operates a specialty Rx distribution platform that automates medication refills according to prescription schedules, acting as an intermediary between patients, prescribers, manufacturers, and pharmacists. Phil also offers complimentary home delivery services for medications. Its technology-driven approach aims to remove barriers to medication access, ensuring seamless therapy initiation and adherence. By providing end-to-end visibility into the prescription life cycle, Phil helps maximize reimbursement for brands while enhancing patient outcomes and provider experiences.

BYJU'S

Series F in 2021
BYJU'S is a prominent global ed-tech company founded in India in 2011, dedicated to providing adaptive and engaging learning solutions to over 150 million students worldwide. The company aims to make high-quality education accessible to learners of all ages through its flagship product, BYJU's: The Learning App, and a diverse portfolio that includes brands such as Disney-BYJU's Early Learn, BYJU's FutureSchool, and WhiteHat Jr. BYJU'S employs personalized learning methodologies that cater to individual learning styles and paces, supported by a network of over 12,000 teachers. The platform utilizes original content, watch-and-learn videos, animations, and interactive simulations to create a contextual and practical learning experience. Additionally, BYJU'S has formed innovative partnerships with major companies like Disney and Google to enhance engagement. Headquartered in India, BYJU'S operates in more than 21 countries and offers programs in over 8 languages, further solidifying its position as a leader in the education technology sector.

Loft

Series D in 2021
Loft is a Brazilian real estate technology company that operates a transactional marketplace and online property platform. Founded in 2018 and based in São Paulo, Loft provides an end-to-end digital workflow to manage home buying and selling, facilitating transactions for individuals, brokers, and publicly listed REITs. The platform combines proprietary transaction data with a searchable property database and integrated services to streamline search, valuation, and deal execution, bringing the Brazilian homebuying experience into the e-commerce era. It offers access to residential and commercial properties, with user feedback and ratings supporting transparent transactions. Loft aims to simplify real estate deals through digital tools and data-driven processes, reducing friction in buying and selling properties across the Brazilian market.

Igneo

Seed Round in 2021
Igneo is a company focused on addressing the challenges of electronic waste (e-waste) through its innovative recycling services. By utilizing patented multi-hearth technology, Igneo transforms raw, low-grade e-waste into sustainable and high-quality metal concentrates, recovering up to 98% of the precious metal content. This process not only offers a cleaner and more efficient alternative to traditional mining and metal recycling but also mitigates harmful emissions commonly associated with conventional methods. Igneo's closed-loop model involves the collaboration of original equipment manufacturers (OEMs) and smelters, reinforcing its commitment to environmentally friendly practices and promoting a more sustainable approach to resource management.

Brightvine

Seed Round in 2021
Brightvine develops a blockchain-based platform that facilitates faster, cheaper, and easier asset sales and financing. It combines decentralized finance with global fixed-income market access, enabling investors to explore new opportunities while providing institutions with enhanced liquidity.

Creditas

Series E in 2020
Creditas is a financial technology company that operates a digital platform that offers secured consumer loans. It uses credit scoring systems and borrowers’ assets, such as homes and automobiles as collateral to offer loans. Sergio Furio founded BankFacil in 2012 that later became Creditas. It has its headquarters in São Paulo in Brazil.

Cue

Series C in 2020
Cue Health Inc. is a healthcare technology company based in San Diego, California, specializing in the development and manufacturing of diagnostic screening devices for home use. Founded in 2010, the company offers a connected diagnostic platform known as the Cue Health Monitoring System, which allows users to conduct self-serve tests that provide lab-quality results. This platform enables individuals to track key health indicators, including inflammation, vitamin D, fertility, influenza, and testosterone, through a user-friendly device that connects to a smartphone app. The Cue app not only displays test results but also integrates data on lifestyle factors such as activity and sleep, facilitating a comprehensive view of health at a molecular level. Additionally, Cue Health provides various services for healthcare professionals, including tools for managing patient test histories and telemedicine consultations. The company's innovative approach empowers consumers and healthcare providers alike to access critical health information easily and effectively.

Petal

Series C in 2020
Petal Card, Inc. is a credit card company focused on providing financial access to individuals without traditional credit histories, such as students and immigrants. Founded in 2015 and based in New York, the company utilizes machine learning to analyze users' digital financial records, allowing for cash flow underwriting as an alternative to conventional credit scoring. This innovative approach enables Petal to offer higher credit limits and lower rates compared to competing credit cards. The company's flagship product, the Petal Visa, is designed to promote responsible spending and credit-building, accompanied by a user-friendly digital application for managing payments. Petal aims to make credit more honest, simple, and accessible, fostering a financial environment that encourages users to succeed.

Nubank

Series F in 2019
Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.

Phil

Series B in 2019
Phil, Inc., founded in 2015 and based in San Francisco, California, specializes in improving patient access to essential medications through its innovative prescription management software. The company operates a specialty Rx distribution platform that automates medication refills according to prescription schedules, acting as an intermediary between patients, prescribers, manufacturers, and pharmacists. Phil also offers complimentary home delivery services for medications. Its technology-driven approach aims to remove barriers to medication access, ensuring seamless therapy initiation and adherence. By providing end-to-end visibility into the prescription life cycle, Phil helps maximize reimbursement for brands while enhancing patient outcomes and provider experiences.

Fathom

Venture Round in 2019
Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.

TrueMotion

Venture Round in 2019
TrueMotion, Inc. is a Boston-based company that develops a smartphone-based telematics platform for insurance companies, aimed at enhancing driving safety. Founded in 2012 and previously known as Censio, the company utilizes advanced signal processing, machine learning, and data science to analyze smartphone sensor data. This technology allows insurers to differentiate between safe and risky drivers, rewarding safe driving behaviors with discounts on premiums. By promoting safer driving practices, TrueMotion contributes to reducing the number of driving accidents and fostering safer roads for all motorists.

Overseas Network

Seed Round in 2019
Overseas Network is a vast large network committed to giving insider info to travel experts for all traveller needs.

Metallica Commodities

Private Equity Round in 2019
Metallica Commodities is a trading company focused on non-ferrous and ferrous metal-containing materials, emphasizing the recycling of printed circuit boards. The company is engaged in the trading of metals and minerals, as well as the development of mineral assets. Its mineral asset projects are located in several countries, including Guyana, Uganda, Tanzania, and the Democratic Republic of the Congo. Additionally, Metallica Commodities processes aggregates and dimension stones, contributing to its diverse portfolio in the metals and minerals sector. Notably, it operates the world's first industrial facility dedicated to the recycling of printed circuit boards, highlighting its commitment to innovation and sustainability within the industry.

Cue

Series B in 2018
Cue Health Inc. is a healthcare technology company based in San Diego, California, specializing in the development and manufacturing of diagnostic screening devices for home use. Founded in 2010, the company offers a connected diagnostic platform known as the Cue Health Monitoring System, which allows users to conduct self-serve tests that provide lab-quality results. This platform enables individuals to track key health indicators, including inflammation, vitamin D, fertility, influenza, and testosterone, through a user-friendly device that connects to a smartphone app. The Cue app not only displays test results but also integrates data on lifestyle factors such as activity and sleep, facilitating a comprehensive view of health at a molecular level. Additionally, Cue Health provides various services for healthcare professionals, including tools for managing patient test histories and telemedicine consultations. The company's innovative approach empowers consumers and healthcare providers alike to access critical health information easily and effectively.

Envisics

Seed Round in 2018
Envisics Limited is an automotive technology company based in Milton Keynes, United Kingdom, specializing in the design and development of holographic projection systems and computation algorithms for head-up and head-mounted displays. Founded in 2009, the company focuses on light manipulation through phase-only holography, leveraging advanced holographic and laser-based technologies to deliver high-quality images. Envisics aims to transform automotive displays and enhance the in-car experience by partnering with leading automakers and tier-one suppliers. Its dynamic holography platform enables the creation of head-up display images that overlay information seamlessly onto the driver’s field of view, thereby improving safety and providing essential driving information without distraction.

Nvoicepay

Series F in 2016
Nvoicepay, Inc. is a fintech company that specializes in cloud-based accounts payable software solutions. Founded in 2009 and headquartered in Beaverton, Oregon, with an additional office in San Francisco, California, Nvoicepay offers payment automation software that enables clients to pay invoices electronically, optimizing payment processes. The company's services include a payment command center, supplier enablement, and both customer and supplier payment support, aimed at streamlining accounts payable operations. By facilitating electronic payments to the right suppliers, Nvoicepay helps organizations reduce costs, enhance efficiencies, and maximize financial benefits, such as card rebates. As of 2019, Nvoicepay operates as a subsidiary of FleetCor Technologies, Inc., continuing to focus on delivering strategic payment solutions tailored for complex enterprises.

Asana BioSciences

Seed Round in 2014
Asana BioSciences, LLC is a clinical-stage biopharmaceutical company located in Bridgewater, New Jersey, specializing in the discovery and development of innovative targeted therapies. Operating as a subsidiary of Amneal Pharmaceuticals, the company focuses on addressing medical needs in the fields of inflammation, immunology, oncology, and pain management. Asana BioSciences engages in early-stage drug discovery and development, providing valuable research and development services to the healthcare industry. Its portfolio includes multiple drug candidates aimed at creating new treatment options for both physicians and patients, thereby enhancing the potential for successful commercialization of its products.

DAQRI

Private Equity Round in 2013
DAQRI LLC is a company based in Los Angeles, California, specializing in augmented reality (AR) solutions aimed at enhancing workplace efficiency and safety. Founded in 2007, DAQRI develops a range of products, including its flagship 4D Studio, a web-based authoring tool designed for creating and managing immersive 4D experiences. The company also offers professional-grade AR wearables, such as smart glasses and helmets, which integrate digital content with the physical environment to streamline communication and productivity. Additionally, DAQRI provides industrial applications for sectors such as aerospace, healthcare, manufacturing, and education, focusing on training, maintenance, and real-time quality assurance. Its offerings include tools for visualizing data in augmented reality, as well as enterprise software and hardware integration services. With a presence in major U.S. cities and a commitment to driving innovation, DAQRI aims to empower workforces across various industries by improving operational processes and effectiveness.

Kashiv BioSciences

Seed Round in 2011
Kashiv BioSciences is a biopharmaceutical company specializing in the development and manufacturing of complex pharmaceuticals, including biosimilars and complex generics. With facilities in Piscataway (NJ), Chicago (IL), and Ahmedabad (India), Kashiv offers capabilities such as cell line development, advanced analytics, and commercial-scale manufacturing. Its pipeline includes KSHB002, an abatacept biosimilar that showed positive Phase I trial results.

Prolong Pharmaceuticals

Seed Round in 2009
Prolong Pharmaceuticals, LLC, established in 2002 and headquartered in South Plainfield, New Jersey, specializes in developing biopharmaceutical products for treating hematology and oncology diseases. Its primary product, SANGUINATE, facilitates oxygen transfer to deprived cells and tissues, focusing on sickle cell disease comorbidities and anemia-related disorders. Additionally, Prolong offers ANF-Rho, EPEG, PP-403, and other investigational drugs targeting various blood and cancer conditions. The company also provides custom manufacturing services and licenses its products to pharmaceutical companies.

Lereta

Private Equity Round in 2009
LERETA specializes in providing property tax data and flood hazard status information tailored for the mortgage and insurance industries across the United States. The company offers a technology-driven platform that facilitates regulatory-compliant property tax tracking, payment services, tax department outsourcing, and federally mandated flood zone certifications. By leveraging software-as-a-service (SaaS) technology, LERETA enables clients to enhance workflow management and automate various processes, ultimately improving efficiency and reducing potential penalties and liabilities. With a strong focus on customer service, LERETA's team of dedicated real estate tax and flood professionals, supported by experienced management, positions the company as a leader in service and technological innovation within its sector.

Amneal Pharmaceuticals

Post in 2005
Amneal Pharmaceuticals develops, manufactures, markets, and distributes generic and specialty pharmaceutical products. Its portfolio spans various dosage forms and therapeutic areas, with a focus on complex oral solids, injectables, and branded products for central nervous system disorders. The company operates in the United States, India, Ireland, and internationally, serving wholesalers, distributors, hospitals, and pharmacies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.